Australia markets open in 56 minutes

bioMérieux S.A. (0RUG.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
105.37+0.52 (+0.50%)
At close: 05:19PM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 312.65%
S&P500 52-week change 316.10%
52-week high 3105.30
52-week low 377.50
50-day moving average 393.95
200-day moving average 395.32

Share statistics

Avg vol (3-month) 352.23k
Avg vol (10-day) 332.76k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 842.89M
% held by insiders 164.28%
% held by institutions 119.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.85
Trailing annual dividend yield 30.81%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 320 Sept 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 10.43%
Operating margin (ttm)16.46%

Management effectiveness

Return on assets (ttm)7.23%
Return on equity (ttm)9.87%

Income statement

Revenue (ttm)3.7B
Revenue per share (ttm)31.41
Quarterly revenue growth (yoy)6.80%
Gross profit (ttm)2.01B
EBITDA 771.6M
Net income avi to common (ttm)385.9M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-29.20%

Balance sheet

Total cash (mrq)423M
Total cash per share (mrq)3.58
Total debt (mrq)490.7M
Total debt/equity (mrq)13.48%
Current ratio (mrq)2.19
Book value per share (mrq)30.71

Cash flow statement

Operating cash flow (ttm)472M
Levered free cash flow (ttm)167.89M